From: A web-based simulation of a longitudinal clinic used in a 4-week ambulatory rotation: a cohort study
Control group | Intervention group | |||||
---|---|---|---|---|---|---|
Pre-rotation | Post-rotation | P-value | Pre-rotation | Post-rotation | P-value | |
Total score | 62.2 | 68.2 | .023 * | 60.9 | 82.6 | < .001* |
By type of patient encounter: | ||||||
Initial consultation | 59.8 | 70.1 | .023* | 58.6 | 81.6 | < .001* |
Follow-up care | 65.2 | 66.3 | .717 | 63.6 | 83.6 | < .001* |
Diagnosis | 53.2 | 67.1 | .015* | 50.7 | 83.6 | < .001* |
Initiating therapy | 64.9 | 72.5 | .072 | 64.4 | 80.1 | .001* |
Natural history | 52.2 | 71.2 | .094 | 49.6 | 87.0 | < .001* |
Managing treatment | 60.4 | 52.3 | .116 | 54.9 | 74.9 | .003* |
Pregnancy | 63.4 | 63.8 | .944 | 63.5 | 85.5 | .001* |
Practice management | 73.6 | 82.8 | .072 | 71.2 | 80.4 | .039* |
All COCOS cases†: | 66.5 | 70.4 | .152 | 61.5 | 80.1 | < .001* |
Type 1 diabetes | 70.7 | 79.5 | .041* | 68.2 | 85.1 | < .001* |
Graves disease | 68.8 | 65.3 | .537 | 59.6 | 76.6 | .018* |
Hyperprolactinemia | 54.7 | 59.3 | .554 | 50.6 | 77.2 | .001* |
All non-COCOS cases†† | 60.3 | 65.1 | .285 | 60.3 | 84.9 | <.001* |
Type 2 diabetes | 58.0 | 76.3 | .019* | 61.9 | 90.5 | <.001* |
Thyroid nodules | 68.2 | 56.4 | .008* | 68.6 | 78.3 | .060 |
Polycystic ovarian syndrome | 48.8 | 56.1 | .434 | 52.4 | 81.7 | <.001* |